Through the "Gatekeeper Door": Exploiting the Active Kinase Conformation

被引:425
作者
Zuccotto, Fabio [1 ]
Ardini, Elena [2 ]
Casale, Elena [1 ]
Angiolini, Mauro [3 ]
机构
[1] Nerviano Med Sci, Dept Chem Core Technol, I-20014 Nerviano, Italy
[2] Nerviano Med Sci, Dept Cell Biol Signal Transduct, I-20014 Nerviano, Italy
[3] Nerviano Med Sci, Dept Med Chem, I-20014 Nerviano, Italy
关键词
SMALL-MOLECULE INHIBITORS; P38 MAP KINASE; TYROSINE KINASE; PROTEIN-KINASES; STRUCTURAL BASIS; LUNG-CANCER; PHARMACOPHORE APPROACH; DOMAIN MUTATIONS; DRUG-RESISTANCE; POTENT;
D O I
10.1021/jm901443h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:2681 / 2694
页数:14
相关论文
共 60 条
[1]   Targeting the unactivated conformations of protein kinases for small molecule drug discovery [J].
Alton, Gordon R. ;
Lunney, Elizabeth A. .
EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (06) :595-605
[2]  
*AM CHEM SOC, 2009, 237 NAT M AM CHEM SO
[3]   Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes [J].
Angell, Richard M. ;
Angell, Tony D. ;
Bamborough, Paul ;
Bamford, Mark J. ;
Chung, Chun-wa ;
Cockerill, Stuart G. ;
Flack, Stephen S. ;
Jones, Katherine L. ;
Laine, Dramane I. ;
Longstaff, Timothy ;
Ludbrook, Steve ;
Pearson, Rosannah ;
Smith, Kathryn J. ;
Smee, Penny A. ;
Somers, Don O. ;
Walker, Ann L. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (15) :4433-4437
[4]   Biphenyl amide p38 kinase inhibitors 2: Optimisation and SAR [J].
Angell, Richard M. ;
Angell, Tony D. ;
Bamborough, Paul ;
Brown, David ;
Brown, Murray ;
Buckton, Jacky B. ;
Cockerill, Stuart G. ;
Edwards, Chris D. ;
Jones, Katherine L. ;
Longstaff, Tim ;
Smee, Penny A. ;
Smith, Kathryn J. ;
Somers, Don O. ;
Walker, Ann L. ;
Willson, Malcolm .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (01) :324-328
[5]   Activation of tyrosine kinases by mutation of the gatekeeper threonine [J].
Azam, Mohammad ;
Seeliger, Markus A. ;
Gray, Nathanael S. ;
Kuriyan, John ;
Daley, George Q. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2008, 15 (10) :1109-1118
[6]   Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance [J].
Azam, Mohammad ;
Nardi, Valentina ;
Shakespeare, William C. ;
Metcalf, Chester A., III ;
Bohacek, Regine S. ;
Wang, Yihan ;
Sundaramoorthi, Raji ;
Sliz, Piotr ;
Veach, Darren R. ;
Bornmann, William G. ;
Clarkson, Bayard ;
Dalgarno, David C. ;
Sawyer, Tomi K. ;
Daley, George Q. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (24) :9244-9249
[7]   Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition [J].
Backes, A. C. ;
Zech, B. ;
Felber, B. ;
Klebl, B. ;
Mueller, G. .
EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (12) :1409-1425
[8]   Small-molecule inhibitors binding to protein kinase. Part II: the novel pharmacophore approach of type II and type III inhibition [J].
Backes, A. C. ;
Zech, B. ;
Felber, B. ;
Klebl, B. ;
Mueller, G. .
EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (12) :1427-1449
[9]   N-4-Pyrimidinyl-1H-indazol-4-amine inhibitors of Lck:: Indazoles as phenol isosteres with improved pharmacokinetics [J].
Bamborough, Paul ;
Angell, Richard M. ;
Bhamra, Inder ;
Brown, David ;
Bull, James ;
Christopher, John A. ;
Cooper, Anthony W. J. ;
Fazal, Lynsey H. ;
Giordano, Ilaria ;
Hind, Lucy ;
Patel, Vipulkumar K. ;
Ranshaw, Lisa E. ;
Sims, Martin J. ;
Skone, Philip A. ;
Smith, Kathryn J. ;
Vickerstaff, Emma ;
Washington, Melanie .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (15) :4363-4368
[10]   Kinase Domain Mutations in Cancer: Implications for Small Molecule Drug Design Strategies [J].
Bikker, Jack A. ;
Brooijmans, Natasja ;
Wissner, Allan ;
Mansour, Tarek S. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (06) :1493-1509